Brief: Akebia Therapeutics Says, On May 30, Unit And Panion & BF Biotech Entered A Settlement And License Agreement - Filing
June 2 (Reuters) - Akebia Therapeutics Inc AKBA.O :
* AKEBIA THERAPEUTICS: ON MAY 30, UNIT AND PANION & BF
BIOTECH
ENTERED A SETTLEMENT AND LICENSE AGREEMENT
* AKEBIA THERAPEUTICS: SETTLEMENT AND LICENSE AGREEMENT
ENTERED
WITH ZYDUS WORLDWIDE DMCC, ZYDUS PHARMACEUTICALS (USA) INC. AND
ZYDUS LIFESCIENCES
* AKEBIA THERAPEUTICS INC - PARTIES WILL TERMINATE ALL
ONGOING
LITIGATION AMONG KERYX, PANION AND ZYDUS ON AURYXIA PATENTS
PENDING IN COURT
Further company coverage: AKBA.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Akebia Therapeutics
See all newsAkebia Q1 revenue falls, net income misses analyst estimates on higher expenses
Brief: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers To Its Board Of Directors
Akebia posts wider-than-expected Q4 net loss as higher expenses hurt
Brief: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule